| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |